Tempus AI is a data monopoly in healthcare, training AI for doctors with high growth and institutional backing, but the creator expects further downside before an upside move.
Source Post
Here are the top 3 stocks Healthcare AI to play the 2026 rotation: Regeneron ($REGN) isn’t just a drug comp...
Feb 12, 2026
The creator highlights three AI healthcare stocks to consider for 2026: Regeneron (REGN) as a tech platform for biology, TransMedics (TMDX) as a logistics monopoly for organ transport, and Tempus AI (TEM) as a data monopoly in healthcare AI. The creator provides insights into their business models, valuations, and potential price movements.
Linked Mentions
Tickers discussed in this post
TransMedics Group is a monopoly in organ transport, offering a prime entry point after its valuation cooled, with technicals suggesting a potential rise to $175.
Regeneron is a tech platform for biology that automates drug discovery, trading at a reasonable valuation with high margins, but the creator suggests waiting for a dip.
Linked Signals
Tracked calls opened from this post
TMDXbuy opened Feb 12, 2026
-44.27%